Xepi
Drug Dermatology
NDC 70363-011-30
General payments
$953,804
Research payments
$97,390
Through program year 2024, $953,804 in general payments and $97,390 in research payments were reported against Xepi (Dermatology).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
7 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | General | $159,249 | 5,314 |
| 2023 | General | $205,727 | 5,565 |
| 2023 | Research | $97,390 | 8 |
| 2022 | General | $190,358 | 4,307 |
| 2021 | General | $113,626 | 3,475 |
| 2020 | General | $40,875 | 1,093 |
| 2019 | General | $243,969 | 2,606 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2024.
The top 5 of 60 specialties; each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.
The top 5 of 48 states; each share is of general payments naming this product in 2024 where a state was reported.
Records
22,360 general · 8 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.